Trade PerkinElmer, Inc. - PKI CFD

Add to favourite

100.71

1.49%

View detailed chart

To be able to trade stocks like this, create an account and apply for a stock listing.

Create Account

Summary
Historical Data
Events
Income Statement
Balance Sheet
Cash Flow

Trading сonditions

Spread

0.19

Long position overnight fee

-0.026179%

Short position overnight fee

0.003957%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

USD

Margin

Stock exchange

United States of America

Commission on trade

*Information provided by Capital.com

Revvity Inc ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats

Prev. Close*	99.23
Open*	99.27
1-Year Change*	-26%
Day's Range*	99.27 - 101.43
52 wk Range	79.50-145.35
Average Volume (10 days)	709.67K
Average Volume (3 months)	18.62M
Market Cap	13.07B
P/E Ratio	62.43
Shares Outstanding	123.41M
Revenue	2.80B
EPS	1.70
Dividend (Yield %)	0.26435
Beta	1.11
Next Earnings Date	Feb 1, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Apr 19, 2024	100.71	1.62	1.63%	99.09	101.52	99.09
Apr 18, 2024	99.23	1.44	1.47%	97.79	100.39	96.29
Apr 17, 2024	100.45	0.51	0.51%	99.94	100.77	98.82
Apr 16, 2024	100.20	-1.04	-1.03%	101.24	101.43	99.75
Apr 15, 2024	102.24	-1.63	-1.57%	103.87	104.39	101.35
Apr 12, 2024	103.41	-3.02	-2.84%	106.43	107.49	103.24
Apr 11, 2024	108.43	0.99	0.92%	107.44	108.93	107.24
Apr 10, 2024	107.78	0.30	0.28%	107.48	108.65	106.06
Apr 9, 2024	110.61	3.18	2.96%	107.43	110.71	106.84
Apr 8, 2024	106.32	4.30	4.21%	102.02	106.85	102.01
Apr 5, 2024	102.14	1.67	1.66%	100.47	103.04	100.43
Apr 4, 2024	101.55	-0.73	-0.71%	102.28	103.81	101.05
Apr 3, 2024	102.29	1.25	1.24%	101.04	103.26	100.81
Apr 2, 2024	102.15	0.22	0.22%	101.93	102.15	100.61
Apr 1, 2024	103.17	-0.21	-0.20%	103.38	104.37	102.98
Mar 28, 2024	104.85	0.37	0.35%	104.48	105.84	102.48
Mar 27, 2024	105.32	2.96	2.89%	102.36	105.58	102.36
Mar 26, 2024	103.29	1.20	1.18%	102.09	103.96	101.93
Mar 25, 2024	102.91	-0.06	-0.06%	102.97	104.10	102.25
Mar 22, 2024	103.14	-0.91	-0.87%	104.05	104.58	102.12

PerkinElmer, Inc. Events

Time (UTC)	Country	Event
Tuesday, April 23, 2024
Time (UTC) 12:00	Country US	Event Revvity Inc Annual Shareholders Meeting Revvity Inc Annual Shareholders Meeting Forecast - Previous -
Wednesday, April 24, 2024
Time (UTC) 12:00	Country US	Event PerkinElmer Inc Annual Shareholders Meeting PerkinElmer Inc Annual Shareholders Meeting Forecast - Previous -
Monday, April 29, 2024
Time (UTC) 12:00	Country US	Event Q1 2024 Revvity Inc Earnings Call Q1 2024 Revvity Inc Earnings Call Forecast - Previous -
Time (UTC) 12:30	Country US	Event Q1 2024 Revvity Inc Earnings Release Q1 2024 Revvity Inc Earnings Release Forecast - Previous -
Tuesday, July 30, 2024
Time (UTC) 12:30	Country US	Event Q2 2024 Revvity Inc Earnings Release Q2 2024 Revvity Inc Earnings Release Forecast - Previous -

View all events

Annual
Quarterly

	2022	2021	2020	2019	2018
Total revenue	3311.82	3827.81	3782.75	2883.67	2778
Revenue	3311.82	3827.81	3782.75	2883.67	2778
Cost of Revenue, Total	1321.99	1393.82	1672.87	1487.62	1437.06
Gross Profit	1989.83	2433.99	2109.88	1396.06	1340.94
Total Operating Expense	2569.12	2569.35	2804.16	2556.71	2441.27
Selling/General/Admin. Expenses, Total	985.114	894.393	896.294	808.718	811.913
Research & Development	221.617	200.337	205.389	189.336	193.998
Unusual Expense (Income)	40.4	80.8	29.613	71.038	-1.7
Operating Income	742.699	1258.46	978.581	326.963	336.728
Interest Income (Expense), Net Non-Operating	-116.12	-88.902	-53.702	-72.132	-65.835
Other, Net	25.258	34.027	-18.515	-17.689	-13.21
Net Income Before Taxes	651.837	1203.58	906.364	237.142	257.683
Net Income After Taxes	512.676	889.436	728.098	230.471	235.45
Net Income Before Extra. Items	512.676	889.436	728.098	230.471	235.45
Total Extraordinary Items	56.503	53.721	-0.211	-2.913	2.477
Net Income	569.179	943.157	727.887	227.558	237.927
Income Available to Common Excl. Extra. Items	512.676	889.436	728.098	230.471	235.45
Income Available to Common Incl. Extra. Items	569.179	943.157	727.887	227.558	237.927
Diluted Net Income	569.179	943.157	727.887	227.558	237.927
Diluted Weighted Average Shares	126.426	116.674	112.085	110.827	111.534
Diluted EPS Excluding Extraordinary Items	4.05515	7.62326	6.49595	2.07956	2.11102
Dividends per Share - Common Stock Primary Issue	0.28	0.28	0.28	0.28	0.28
Diluted Normalized EPS	4.30648	8.13503	6.74545	2.70251	2.09709

	Jul 2023	Apr 2023	Jan 2023	Oct 2022	Jul 2022
Total revenue	709.066	674.865	741.214	711.803	895.642
Revenue	709.066	674.865	741.214	711.803	895.642
Cost of Revenue, Total	306.735	293.499	304.884	304.759	343.926
Gross Profit	402.331	381.366	436.33	407.044	551.716
Total Operating Expense	631.01	598.746	603.745	601.023	663.148
Selling/General/Admin. Expenses, Total	238.413	229.562	245.868	231.469	253.8
Research & Development	57.253	56.69	54.536	53.521	56.036
Unusual Expense (Income)	28.609	18.995	-1.543	11.274	9.386
Operating Income	78.056	76.119	137.469	110.78	232.494
Interest Income (Expense), Net Non-Operating	-2.984	-14.698	-22.376	-30.37	-23.457
Other, Net	-3.518	-31.981	23.354	1.732	-2.693
Net Income Before Taxes	71.554	29.44	138.447	82.142	206.344
Net Income After Taxes	58.622	24.845	97.497	69.508	161.601
Net Income Before Extra. Items	58.622	24.845	97.497	69.508	161.601
Total Extraordinary Items	-23.063	544.63	30.161	15.839	17.611
Net Income	35.559	569.475	127.658	85.347	179.212
Income Available to Common Excl. Extra. Items	58.622	24.845	97.497	69.508	161.601
Income Available to Common Incl. Extra. Items	35.559	569.475	127.658	85.347	179.212
Diluted Net Income	35.559	569.475	127.658	85.347	179.212
Diluted Weighted Average Shares	125.398	126.469	126.426	126.54	126.509
Diluted EPS Excluding Extraordinary Items	0.46749	0.19645	0.77118	0.5493	1.27739
Dividends per Share - Common Stock Primary Issue	0.07	0.07	0.07	0.07	0.07
Diluted Normalized EPS	0.66733	0.33689	0.76258	0.62469	1.33549

Annual
Quarterly

	2022	2021	2020	2019	2018
Total Current Assets	3288.56	2440.78	2238.92	1374.38	1234.63
Cash and Short Term Investments	454.358	618.319	402.036	191.877	163.111
Cash & Equivalents	454.358	618.319	402.036	191.877	163.111
Total Receivables, Net	612.78	1023.79	1155.11	725.184	632.669
Accounts Receivable - Trade, Net	612.78	1023.79	1155.11	725.184	632.669
Total Inventory	405.462	624.714	514.567	356.937	338.347
Other Current Assets, Total	1815.96	173.955	167.208	100.381	100.507
Total Assets	14129.9	15000.6	7960.31	6538.56	5975.52
Property/Plant/Equipment, Total - Net	671.301	753.38	575.54	485.499	318.59
Property/Plant/Equipment, Total - Gross	1045.49	1274.55	1025.43	868.856	680.183
Accumulated Depreciation, Total	-374.193	-521.168	-449.893	-383.357	-361.593
Goodwill, Net	6481.77	7416.58	3447.11	3111.23	2952.61
Intangibles, Net	3377.17	4063.1	1365.69	1283.29	1199.67
Other Long Term Assets, Total	311.054	326.706	333.048	284.173	270.023
Total Current Liabilities	1544.48	1213.74	1652.19	762.832	771.631
Accounts Payable	272.826	355.458	327.325	235.855	220.949
Accrued Expenses	346.707	459.574	450.692	320.754	347.91
Notes Payable/Short Term Debt	0	0	0	0	0
Current Port. of LT Debt/Capital Leases	470.929	4.24	380.948	9.974	14.856
Other Current Liabilities, Total	454.021	394.472	493.224	196.249	187.916
Total Liabilities	6746.98	7859.31	4224.82	3724.74	3390.57
Total Long Term Debt	3923.35	4979.74	1609.7	2064.04	1876.62
Long Term Debt	3923.35	4979.74	1609.7	2064.04	1843.62
Capital Lease Obligations					33
Other Liabilities, Total	169.968	185.359	188.402	146.399
Total Equity	7382.88	7141.25	3735.49	2813.82	2584.96
Preferred Stock - Non Redeemable, Net	0	0	0	0	0
Common Stock	126.3	126.241	112.09	111.14	110.597
Additional Paid-In Capital	2753.05	2760.52	148.101	90.357	48.772
Retained Earnings (Accumulated Deficit)	4951.02	4417.17	3507.26	2811.97	2602.07
Unrealized Gain (Loss)	-0.035	-0.04	-0.277	-0.261	-0.267
Other Equity, Total	-447.462	-162.652	-31.684	-199.385	-176.214
Total Liabilities & Shareholders’ Equity	14129.9	15000.6	7960.31	6538.56	5975.52
Total Common Shares Outstanding	126.3	126.241	112.09	111.14	110.597
Deferred Income Tax	1109.18	1480.47	774.531	751.468	742.312

	Oct 2023	Jul 2023	Apr 2023	Jan 2023	Oct 2022
Total Current Assets	2913.24	3523.34	3795.61	3288.56	3116.48
Cash and Short Term Investments	1429.69	2070.96	2461.15	454.358	400.741
Cash & Equivalents	1136.72	1331.9	2267.18	454.358	400.741
Total Receivables, Net	644.574	626.935	586.922	612.78	540.867
Accounts Receivable - Trade, Net	644.574	626.935	586.922	612.78	540.867
Total Inventory	435.696	436.822	429.423	405.462	378.256
Other Current Assets, Total	403.275	388.626	318.116	1815.96	1796.62
Total Assets	13421.5	14218.5	14638.2	14129.9	13823.8
Property/Plant/Equipment, Total - Net	645.89	657.991	659.067	671.301	620.517
Goodwill, Net	6470.14	6518.42	6505.96	6481.77	6373.33
Intangibles, Net	3085.25	3197.23	3294.66	3377.17	3401.14
Other Long Term Assets, Total	307.029	321.568	382.868	311.054	312.297
Total Current Liabilities	1447.84	1366.83	1563.74	1544.48	1485.73
Accounts Payable	188.302	235.721	266.884	272.826	275.824
Accrued Expenses	532.004	652.173	817.432	527.863	471.57
Notes Payable/Short Term Debt	0	0	0	0	0
Current Port. of LT Debt/Capital Leases	727.539	478.936	479.423	470.929	503.549
Total Liabilities	5727.27	6348.59	6604.35	6746.98	6758.56
Total Long Term Debt	3152.45	3883.74	3880.98	3923.35	3898.27
Long Term Debt	3152.45	3883.74	3880.98	3923.35	3898.27
Other Liabilities, Total	133.922	144.185	149.392	169.968	142.842
Total Equity	7694.28	7869.96	8033.81	7382.88	7065.2
Preferred Stock - Non Redeemable, Net	0		0	0	0
Common Stock	123.349	124.347	125.981	126.3	126.22
Additional Paid-In Capital	2410.77	2512.06	2700.56	2753.05	2754.72
Retained Earnings (Accumulated Deficit)	5539.4	5538.52	5511.65	4951.02	4834.05
Unrealized Gain (Loss)	0.252	0.262	0.259	-0.035	-0.035
Other Equity, Total	-379.492	-305.234	-304.64	-447.462	-649.747
Total Liabilities & Shareholders’ Equity	13421.5	14218.5	14638.2	14129.9	13823.8
Total Common Shares Outstanding	123.349	124.347	125.981	126.3	126.22
Property/Plant/Equipment, Total - Gross				857.143
Accumulated Depreciation, Total				-374.193
Deferred Income Tax	993.046	953.838	1010.23	1109.18	1231.72
Other Current Liabilities, Total	0	0	0	272.865	234.788
Short Term Investments	292.971	739.055	193.963

Annual
Quarterly

	2022	2021	2020	2019	2018
Net income/Starting Line	569.179	943.157	727.887	227.558	237.927
Cash From Operating Activities	679.81	1410.75	892.177	363.469	311.038
Cash From Operating Activities	427	358.004	246.507	214.025	180.588
Deferred Taxes	-105.923	-49.342	-29.121	-61.353	-51.103
Non-Cash Items	52.522	54.566	66.025	147.898	74.354
Cash Taxes Paid	323.077	364.565	162.454	77.059	59.844
Cash Interest Paid	97.934	54.12	42.142	82.693	56.451
Changes in Working Capital	-262.968	104.365	-119.121	-164.659	-130.728
Cash From Investing Activities	-132.851	-4112.76	-504.498	-487.573	-159.859
Capital Expenditures	-85.632	-99.888	-77.506	-81.331	-93.253
Other Investing Cash Flow Items, Total	-47.219	-4012.87	-426.992	-406.242	-66.606
Cash From Financing Activities	-661.803	2941.66	-202.872	150.13	-179.23
Financing Cash Flow Items	-0.767	-51.987	-14.917	-41.101	-49.566
Total Cash Dividends Paid	-35.344	-32.373	-31.212	-31.059	-31.009
Issuance (Retirement) of Stock, Net	-66.524	-47.952	30.727	13.419	-32.612
Issuance (Retirement) of Debt, Net	-559.168	3073.97	-187.47	208.871	-66.043
Foreign Exchange Effects	-33.747	-22.926	25.913	-0.447	-8.004
Net Change in Cash	-148.591	216.723	210.72	25.579	-36.055

	Apr 2023	Jan 2023	Oct 2022	Jul 2022	Apr 2022
Net income/Starting Line	569.475	569.179	441.521	356.174	176.962
Cash From Operating Activities	63.463	679.81	540.652	380.7	283.215
Cash From Operating Activities	109.008	427	322.766	239.457	120.052
Non-Cash Items	-519.438	52.522	88.759	105.327	60.273
Changes in Working Capital	-95.582	-262.968	-312.394	-320.258	-74.072
Cash From Investing Activities	1864.5	-132.851	-107.167	-84.661	-56.306
Capital Expenditures	-20.946	-85.632	-59.502	-52.585	-29.431
Other Investing Cash Flow Items, Total	1885.45	-47.219	-47.665	-32.076	-26.875
Cash From Financing Activities	-113.185	-661.803	-585.106	-519.466	-164.858
Financing Cash Flow Items	-1.475	-0.767	-0.762	-0.762	-0.762
Total Cash Dividends Paid	-8.841	-35.344	-26.502	-17.667	-8.837
Issuance (Retirement) of Stock, Net	-61.133	-66.524	-49.883	-50.207	-54.195
Issuance (Retirement) of Debt, Net	-41.736	-559.168	-507.959	-450.83	-101.064
Foreign Exchange Effects	-16.969	-33.747	-51.404	-33.977	-10.636
Net Change in Cash	1797.81	-148.591	-203.025	-257.404	51.415
Deferred Taxes		-105.923

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

Leverage

1:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

PerkinElmer, Inc. Company profile

About PerkinElmer, Inc.

PerkinElmer, Inc. is a provider of products, services and solutions for the diagnostics, life sciences and applied markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides products and services targeted towards the life sciences and applied markets. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the reproductive health, immunodiagnostics and applied genomics markets. The Company provides early detection for genetic disorders from pregnancy to early childhood, and infectious disease testing for the diagnostics market. It offers its products under various brand names, including AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BoBs, chemagic, Chitas, Datalytix, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROline, EUROPattern, FragilEase, Genoglyphix, GSP, and Haoyuan.

Financial summary

BRIEF: For the fiscal year ended 02 January 2022, PerkinElmer, Inc. revenues increased 34% to $5.07B. Net income before extraordinary items increased 30% to $943.3M. Revenues reflect Diagnostics segment increase of 42% to $2.93B, Discovery & Analytical Solutions segment increase of 24% to $2.14B, Other Foreign segment increase from $839.2M to $1.93B, United States segment increase of 61% to $2.05B, United Kingdom segment increase of 15% to $417.2M.

Equity composition

Common Stock $1 Par, 05/11, 300M auth., 112,761,872 issd., Insiders own 1.01%. IPO 5/65, 150,000 shares @ $27.50 by Kidder Peabody & Co. 6/01, 5/92, 2-for-1 stock splits. *11/01, Company acquired Packard BioScience Company @ 0.311 shares (21,363,882 shares issd.).

Industry:

Advanced Medical Equipment & Technology (NEC)

940 Winter Street
WALTHAM
MASSACHUSETTS 02451
US

Income Statement

Annual
Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024